Given RIPK1’s functions in regulating both immunological and epithelial responses, performing HSCT to treat these sufferers should be taken with caution since it may improve immunodeficiency [7–9, 15, 19]. This evidence concerns the gene RIPK1 and immunodeficiency disease.